Total: 3 |
|
PMID (PMCID) | ||
---|---|---|
20303634 |
FEMALE | |
Decreased kidney function and crystal deposition in the tubules after kidney transplant. | ||
Stratta P, Fogazzi GB, Canavese C, Airoldi A, Fenoglio R, Bozzola C, Ceballos-Picot I, Bollee G, Daudon M. Am J Kidney Dis. 2010;56(3):585-90. |
||
Adenine phosphoribosyltransferase (APRT) deficiency is an autosomal recessive purine enzyme defect that results in the inability to utilize adenine, which consequently is oxidized by xanthine dehydrogenase to 2, 8-dihydroxyadenine (2,8-DHA), an extremely insoluble substance eventually leading to crystalluria, nephrolithiasis, and kidney injury. | ||
20101413 |
MIXED_SAMPLE | Infant |
Two families with compound heterozygosity for adenine phosphoribosyltransferase deficiency. | ||
Iwaki T, Kusaka T, Ohashi I, Nishida T, Imai T, Itoh S. Pediatr Nephrol. 2010;25(6):1173-6. |
||
Crystalluria was the first sign of APRT deficiency, thereafter confirmed by genetic screening for APRT*/Q0 and APRT*. | ||
20101413 |
MIXED_SAMPLE | Infant |
Two families with compound heterozygosity for adenine phosphoribosyltransferase deficiency. | ||
Iwaki T, Kusaka T, Ohashi I, Nishida T, Imai T, Itoh S. Pediatr Nephrol. 2010;25(6):1173-6. |
||
Adenine phosphoribosyltransferase deficiency is a disorder in which 2, 8-dihydroxyadenine (2,8-DHA) crystalluria is caused by a congenital deficiency in the enzyme adenine phosphoribosyltransferase (APRT). |